Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms
- PMID: 35005746
- PMCID: PMC8740858
Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms
Abstract
Objective: To compare the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms.
Methods: 50 neurosyphilis with mental symptoms patients were randomly divided into penicillin group (4 million units, Q4h) and ceftriaxone sodium group (1 g, Q12h). The total treatment time was 14 and 15 days respectively.The activity of daily living scale (ADL), brief psychiatric rating scale (BPRS) and mini-mental state examination (MMSE) were scored as the measurement of efficiency in living ability, mental symptoms and cognitive function.
Result: There were no significant differences in ADL, MMSE and BPRS between the penicillin group and the ceftriaxone sodium treatment group (p > 0.05). After treatment, the score of BPRS and ADL decreased from baseline, while MMSE scores increased from baseline, having a main time effect (F=31.098,F=26.342,F= 79.916; p < 0.05).
Conclusion: Penicillin or ceftriaxone sodium are both effective in the aspect of mental symptoms, cognitive function and life ability among neurosyphilis with psychiatric symptoms patients.
Keywords: ceftriaxone sodium; clinical efficacy; neurosyphilis; penicillin; psychiatric symptoms.
Conflict of interest statement
Conflict of Interest: None.
Similar articles
-
Ceftriaxone compared with penicillin G for the treatment of neurosyphilis: study protocol for a multicenter randomized controlled trial.Trials. 2022 Oct 1;23(1):835. doi: 10.1186/s13063-022-06769-w. Trials. 2022. PMID: 36183101 Free PMC article.
-
A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals.Clin Infect Dis. 2000 Mar;30(3):540-4. doi: 10.1086/313725. Clin Infect Dis. 2000. PMID: 10722441 Clinical Trial.
-
Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus.Am J Med. 1992 Nov;93(5):481-8. doi: 10.1016/0002-9343(92)90574-u. Am J Med. 1992. PMID: 1442850
-
[Current aspects of neurosyphilis: therapy-resistant cases with high-dosage penicillin?].Schweiz Rundsch Med Prax. 1992 Dec 1;81(49):1473-80. Schweiz Rundsch Med Prax. 1992. PMID: 1462068 Review. German.
-
Antibacterial therapy of neurosyphilis: lack of impact of new therapies.CNS Drugs. 2002;16(12):799-802. doi: 10.2165/00023210-200216120-00001. CNS Drugs. 2002. PMID: 12421113 Review.
Cited by
-
Expanding Horizons in Syphilis Treatment: Challenges, Advances, and Opportunities for Alternative Antibiotics.Curr HIV/AIDS Rep. 2025 Mar 13;22(1):22. doi: 10.1007/s11904-025-00725-4. Curr HIV/AIDS Rep. 2025. PMID: 40074945 Free PMC article. Review.
-
CARE-NS, a research strategy for neurosyphilis.Front Med (Lausanne). 2023 Jan 6;9:1040133. doi: 10.3389/fmed.2022.1040133. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687428 Free PMC article.
References
-
- The L. Syphilis: an ancient disease in a modern era. Lancet. 2017;389(10078):1492. - PubMed
-
- Wang J, Guo Q, Zhou P, Zhang J, Zhao Q, Hong Z. Cognitive impairment in mild general paresis of the insane: AD-like pattern. Dementia and geriatric cognitive disorders. 2011;31(4):284–90. - PubMed
-
- Stefani A, Riello M, Rossini F, Mariotto S, Fenzi F, Gambina G, et al. Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013;34(11):2027–30. - PubMed
-
- Roberts MC, Emsley RA. Cognitive change after treatment for neurosyphilis. Correlation with CSF laboratory measures. General hospital psychiatry. 1995;17(4):305–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources